Physician profile
Brooke N Counce
NPI 1922630417
$11,765.78
in general payments reported to CMS, 2019-2025
42 companies · $2,905 in 2025
The $2,905 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,120 · 2022: $2,228 · 2023: $3,403 · 2024: $2,110 · 2025: $2,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,312 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,312.42 |
| Education | $105.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,746.97 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $1,534.16 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,138.72 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $888.52 | 2021-2025 | Dupixent |
| Genzyme Corporation | $883.50 | 2021-2025 | |
| Insmed, INC. | $711.53 | 2022-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $599.68 | 2021-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $556.49 | 2021-2025 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $387.89 | 2021-2024 | Yupelri |
| Inspire Medical Systems, INC. | $371.49 | 2022-2025 | Inspire |
| United Therapeutics Corporation | $361.56 | 2022-2025 | Tyvaso, Tyvaso |
| Jazz Pharmaceuticals INC. | $332.34 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $267.36 | 2023-2025 | Winrevair, Zerbaxa, Keytruda |
| Verona Pharma, INC. | $234.50 | 2025 | Ohtuvayre |
| Baxter Healthcare | $187.83 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Counce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.